“When most people think about cancer treatment, they think solely of chemotherapy. But these days we are really lucky to have access to a whole library of options, so it has become more about precision medicine which is specific to the patient and their unique situation, as opposed to a ‘one size fits all’ treatment approach. We also now have the ability to characterise a cancer down to the molecular level, which provides a more comprehensive understanding of how that particular cancer may respond to our treatments.” 

Such treatment options may include endocrine (hormone) therapy, antibody-drug conjugates, targeted agents, immunotherapy, chemotherapy, surgery, radiation, or often a mix of these. Molecular profiling of breast cancer may also identify patients who can safely forgo some of these treatments.

“The last 5 – 10 years especially has seen a lot of innovation when it comes to breast cancer treatment, which has really changed the playing field. Much of this can be attributed to cutting-edge research, funding and the incredible support provided by advocacy groups. Treatment options are rapidly evolving and with this comes greater rates of survival for those with early-stage breast cancer, and the ability to buy more time and quality of life for those whose cases are more advanced.”

Meeting people at what is often the worst time of their lives, Dr McCartney describes the role she plays in their cancer journey as a ‘privilege.’

“Patients place a lot of trust in us to provide them with the very best care when they are at their most vulnerable. I feel lucky to work as part of a multidisciplinary team at VBOC, where we develop and deliver a personalised treatment plan for each individual. Getting to be a part of their journey – sharing both the good times and the bad times - knowing I have made a real difference at the coal face, is a real privilege.’

To learn more about Dr McCartney and the VBOC team visit www.vboc.com.au